 |
Representative Issued Patents Drafted by Warren Woessner
Biofuels/Bioenergy
- "Soybean Oil Ester Fuel Blends" U.S. Pat. No. 5520798
- "Use of Mesoporous Silicates to Transesterify Oils" U.S. Pat. No. 7122688
Pharmaceuticals, biologicals
- Altana, Inc. (US Pat No 7,300,669) "Fluticasone Lotion Having Improved Vasoconstrictor Activity"
- University of Missouri (US Pat No 7,214,224) "Peptidyl Prodrugs that Resist P-Glycoprotein Mediated Drug Efflux"
- University of Virginia (U.S. Pat No 7,214,665) "2-Propynyl Adenosiine Analogs" Orphan Medical, Inc. (U.S. Pat No 7,262,219) "
- Microbiologically Sound and Stable Solutions of Gamma-Hydroxybutyrate Salt"
- Orphan Medical, Inc. (US Pat No 7015200): "Gamma Hydroxy Butyrate Compositions"
- NeoRx, High Dose Radionuclide Complexes for Bone Marrow Suppression (US Pat No 6767531)
- Aesgen, Inc. (U.S. Patent No. 7,041,651); CELLULAR UPTAKE OF BIOACTIVE AGENTS
- Orphan Medical, Inc. (U.S. Patent No. 7,015,200); GAMMA-HYDROXYBUTYRATE COMPOSITIONS CONTAINING CARBOHYDRATE, LIPID OR AMINO ACID CARRIERS
- Neurosearch (U.S. Patent No. 6,288,079): TROPANE-DERIVATIVES, THEIR PREPARATION AND USE
- Aesgen, Inc. (U.S. Patent No. 6,268,524): METHOD FOR PREPARATION OF DISODIUM PAMIDRONATE
- University of Virginia (U.S. Patent No. 6,232,297): METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY RESPONSE
- University of California (U.S. Pat. No. 6,069,283): ILLUDIN ANALOGS USEFUL AS ANTITUMOR AGENTS
- University of Minnesota (U.S. Pat. No. 5,962,684): METHOD OF PREPARATION OF DIDEOXYCARBOCYCLIC NUCLEOSIDES
- University of Minnesota (U.S. Pat. No. 5,929,087): DECAHYDROQUINOLINE-BASED ANTI-CHOLINERGIC AGENTS
- Mayo Clinic (U.S. Patent No. 5,783,584): THA ANALOGS USEFUL AS CHOLINESTERASE INHIBITORS
- Research Corp. Technologies (U.S. Patent No. 5,840,859): (AMINOSTYRYL) PYRIDIUM COMPOUNDS FOR RADIOLABELLING CELL MEMBRANES
- Research Corp. Technologies (U.S. Patent No. 5,648,378): 2-IMINOCHROMENE DERIVATIVES AS INHIBITORS OF PTK
- Iowa State U (U.S. Patent No. 5,721,371): SYNTHESIS OF SUBSTITUTED PTEROCARPANS
- Wake Forest U (U.S. Patent No. 5,512,671): ETHER LIPID-NUCLEOSIDE COVALENT CONJUGATES
- Mayo Clinic (U.S. Patent No. 5,391,744): COCAINE ANALOGS
- U of California (U.S. Patent No. 5,439,942): METHOD OF TREATING CERTAIN TUMORS USING ILLUDIN ANALOGS
- RCT (U.S. Patent No. 5,472,956): PHOSPHORAMIDATES USEFUL AS ANTITUMOR AGENTS
- U of Minnesota (U.S. Patent No. 5,616,575): BIOACTIVE TRICYCLIC IBOGAINS ANALOGS
- U of Minnesota (U.S. Patent No. 5,457,208): KAPPA OPIOID RECEPTOR ANTAGONISTS
- U of Minnesota (U.S. Patent No. 5,298,622): SPIROINDANE OPIATE ANALOGS
- U.S. Patent No. 4,950,758 "OPTICALLY ACTIVE ISOMERS OF DIDEOXYCARBOCYCLIC NUCLEOSIDES"
- U.S. Patent No. 5,001,117 "Use of Lecithin to Restore Olefaction and Taste"
- U.S. Patent No. 5,227,508 "Analogs of Phosphatidylinositol"
- U.S. Patent No. 5,233,031 "Phosphoramidate Analogs of 2¢-Deoxyuridine"
- U.S. Patent No. 5,233,059 "Synthesis of Benzoprostacyclins"
- U.S. Patent No. 5,268,480 "Cocaine Analogs"
- U.S. Patent No. 5,298,622 "Spiroindane Opiate Analogs"
- U.S. Patent No. 5,306,727 "Phosphoramidates Useful as Antitumor Agents"
- U.S. Patent No. 5,359,087 "Bioactive Quisqualic Acid Analogs"
top
Genes and Gene Therapy
- Mayo Clinic/Hybritech, Inc. (U.S. Pat. No. 6013471): DNA ENCODING VARIANT HK2 POLYPEPTIDES.
- Mayo Clinic (U.S. Patent No. 5,470,737): STABLY-TRANSFORMED CELLS EXPRESSING HUMAN THIOPURINE METHYLTRANSFERASE
- Mayo Clinic (U.S. Patent No. 5,744,355): CLONING AND EXPRESSION OF HUMAN LIVER ESTROGEN TRANSFERASE
- Mayo Clinic (U.S. Patent 5,618,695): DNA ENCODING HEM-1
- University of rochester (U.S. Patent 5,601,818): CANCER THERAPY UTILIXING MALIGNANT CELLS EXPRESSING HSV-TK
top
Microogranisms/Cell Culture Technology
- University of Minnesota (US. Patent No. 6,277,557): INFUSABLE GRADE SHORT-TERM CELL STORAGE MEDIUM
- Albany Medical College (US. Pat. No. 5,908,624): Antigenic Modulation of Cells.
- U of Minnesota (U.S. Patent No. 5,508,193): PSEUDOMONAS STRAIN FOR DEGRADATION OF S-TRIAZINES IN SOIL AND WATER
- U of Minnesota (U.S. Patent No. 5,460,964): METHOD FOR CULTURING HEMATOPOIETIC CELLS
- U of Minnesota (U.S. Patent No. 5,436,151): METHOD FOR CULTURING HUMAN HEMATOPOIETIC STEM CELLS IN VITRO
- Mayo Clinic (U.S. Patent No. 5,693,511): IMMORTALIZED HUMAN FETAL OSTEOBLASTIC CELLS
top
Monoclonal Antibodies and Diagnostic Methods
- Aesgen, Inc. (U.S. Pat. No. 7186517): "Compostions and Methods for Monitoring Breast Cancer Treatment"
- Research Corporation Technologies, Inc.(U. S. Pat. No. 6106834): USE OF ANTI-CD45 LEUKOCYTE ANTIGEN ANTIBODIES FOR IMMUNOMODULATION.
- University of Minnesota (U.S. Pat. No. 5919457): TXU-5/B53-APA ANTVIRAL THERAPEUTIC AGENT FOR THE TREATMENT OF AIDS.
- Mayo Clinic (U.S. Pat. No 5827497): CHARCOAL - RADIONUCLIDE AGENTS FOR MEASUREMENT OF GASTROINTESTINAL TRANSIT.
- Mayo Clinic (U.S. Patent No. 5,529,902): DIRECT FLUORESCENCE-CONJUGATED IMMUNOASSAY FOR PLATELET ACTIVATION
- NeoRx (U.S. Patent No. 5,545,569): METHODS TO DETERMINE TGF-BETA
- U of Minnesota (U.S. Patent No. 5,434,050): LABELLED BETA-AMYLOID PEPTIDE AND METHODS OF SCREENING FOR ALZHEIMER'S DISEASE
- U of Minnesota (U.S. Patent No. 5,316,907): ENZYMATIC FLUOROMETRIC ASSAY FOR ADENYLATE CYCLASE
- Mayo Clinic (U.S. Patent No. 5,516,639): ANTIBODIES SPECIFIC FOR HUMAN PROSTATE GLANDULAR KALLIKREIN
- U.S. Patent No. 4,806,464) "Nuclear Binding Assay for Steroid Receptor Functionality in Cancerous Cells"
- U.S. Patent No. 5,256,540) "Immunoassay for Small Cell Lung Carcinoma"
- U.S. Patent No. 5,298,605) "Antibodies to Islet Amyloid Polypeptide"
- U.S. Patent No. 5,316,907) "Enzymatic Fluorometric Assay for Adenylate Cyclase"
top
Enzymology
- Iowa State University (U.S. Pat. No. 5,804,426): RECOMBINANT CYCLODEXTRAN GLUCANOTRANSFERASE MUTANTS
- Research Corporations Technologies (U.S. Patent No. 5,728,804): USE OF CYCLODEXTRINS FOR PROTEIN RENADRATION
- Iowa State (U.S. Patent No. 5,804,426): RECOMBINANT CYCLODEXTRAN GLUCANOTRANSFERASE MUTANTS
top
Polypeptides
- Research Corporation Technologies, Inc. (U.S. Patent No. 7,011,831); RECOMBINANT [alpha symbol]-GALACTOSIDASE A THERAPY FOR FABRY DISEASE
- Orphan Medical (US. Patent No. 6,210,666): TRUNCATED ALPHA-GALA TO TREAT FABRY DISEASE
- Hybritech, Inc. (US. Patent No. 6,103,237): STABLE VARIANT HK2 POLYPEPTIDE
- Mayo Clinic (US Patent No. 6,093,796): RECOMBINANT HK2 POLYPEPTIDE
- Mayo Clinic (U.S. Patent No. 5,583,108): VASONATRIN PEPTIDE
- Mayo Clinic/Hybritech, Inc. (U.S. Pat. No. 6093796): RECOMBINANT HK2 POLYPEPTIDE
- U of Minnesota (U.S. Patent No. 5,557,033): METHOD OF INCREASING EGG PRODUCTION IN AVIAN SPECIES BY ACTIVE IMMUNIZATION AGAINST VASOACTIVE INTESTINAL PEPTIDE
- U of Minnesota (U.S. Patent No. 5,523,286): A STROMA-DERIVED PROTEOGLYCAN CONTAINING COMPOSITION WHICH PROMOTES DIFFERENTIATION AND MAINTAINS THE SELF-RENEWAL CAPACITY OF LONG-TERM BONE MARROW CULTURE-INITIATING CELLS
- U of Minnesota (U.S. Patent No. 5,424,221): KIT FOR DETECTION OF ISLET AMYLOID POLYPEPTIDE (IAPP)
- U.S. Patent No. 5,019,646) "Polypeptides with Fibronectin Activity"
- U.S. Patent No. 5,158,884) "Immunodominant Acetycholine Receptor Peptides"
- U.S. Patent No. 5,260,308) "Method to Increase Permeability of the Blood-Nerve/Brain Barriers to Proteins"
top
Agricultural Biotechnology
- DEKALB Genetics Corp. (U.S. Pat. No. 6,025,545): METHODS AND COMPOSITIONS FOR THE PRODUCTION OF STABLY TRANSFORMED, FERTILE MONOCOT PLANTS
- DEKALB Genetics Corp. (U.S. Pat. No. 6,013,863): FERTILE TRANSGENIC CORN PLANTS
- Dekalb (U.S. Patent No. 5,538,880): METHOD FOR PREPARING FERTILE TRANSGENIC CORN PLANTS
- Dekalb (U.S. Patent No. 5,538,877): METHOD FOR PREPARING FERTILE TRANSGENIC CORN PLANTS
- Dekalb (U.S. Patent No. 5,484,956): FERTILE TRANSGENIC ZEA MAYS PLANT COMPRISING HETEROLOGOUS DNA ENCODING BACILLUS THURINGIENSIS ENDOTOXIN
- Dekalb (U.S. Patent No. 5,554,798): FERTILE GLYPHOSATE-RESISTANT TRANSGENIC CORN PLANTS
- University of Minnesota (U.S. Patent No. 5,773,269): FERTILE TRANGENIC OAT PLANTS
- U.S. Patent No. 5,162,602) "Corn Plants Tolerant of Sethoxydim and Haloxyfop Herbicides"
- U.S. Patent No. 5,258,300) "Method of Inducing Lysine Overproduction in Plants"
- U.S. Patent No. 5,384,253) "Genetic Transformation of Maize by Electroporation"
top
Methods of Medical Treatment
- Aesgan, Inc. (U.S. Patent No. 6,734,170); CELLULAR UPTAKE OF BIOACTIVE AGENTS
- NeoRx Corporation (U.S. Patent No. 6,767,531); HIGH DOSE RADIONUCLIDE COMPLEXES FOR BONE MARROW SUPPRESSION
- NeoRx Corporation (U.S. Patent No. 7,070,759); HIGH DOSE RADIONUCLIDE COMPLEXES FOR BONE MARROW SUPPRESSION
- Indiana University Research and Technology Corporation (U.S. Patent No. 6,890,946); USE OF PARTHENOLIDE TO INHIBIT CANCER
- Mayo Clinic (US Patent No. 6,297,229): USE OF USE OF URSODEOXYCHOLIC ACID TO TREAT NONALCOHOLIC STEATOHEPATITIS
- NeoRx (U.S. Pat. No. 5,945,456): PREVENTION AND TREATMENT OF PATHOLOGIES ASSOCIATED WITH ABNORMALLY PROLIFERATIVE SMOOTH MUSCLE CELLS
- Mayo Clinic (U.S. Pat. No. 5,837,713): TREATMENT OF EOSINOPHIL-ASSOCIATED PATHOLOGIES
- University of Minnesota (U.S. Pat No. 5,780,479): USE OF OPIOID ANTAGONISTS TO TREAT IMPULSE CONTROL DISORDERS
- Mayo Clinic (U.S. Patent No. 5,691,343): USE OF TOPICAL AZATHIOPRENE TO TREAT INFLAMMATORY BOWEL DISORDERS
- Mayo Clinic (U.S. Patent No. 5,510,339): METHOD FOR TREATMENT OF BRONCHIAL ASTHMA BY ADMINISTRATION OF TOPICAL ANESTHETICS
- Center for Innovative Technology (U.S. Patent No. 5,541,226): TOPICAL COMPOSITIONS FOR RE-EPITHELIALIZATION OF PERSISTENT EPITHELIAL DEFECTS
- Gleich (U.S. Patent No. 5,498,410): METHOD FOR THE TREATMENT OF EOSINOPHIL-ASSOCIATED CONDITIONS WITH ANIONIC POLYMERS
- NeoRx (U.S. Patent No. 5,472,985): PREVENTION AND TREATMENT OF PATHOLOGIES ASSOCIATED WITH ABNORMALLY PROLIFERATIVE SMOOTH MUSCLE CELLS
- U of Minnesota (U.S. Patent No. 5,411,965): USE OF DELTA OPIOID RECEPTOR ANTAGONISTS TO TREAT COCAINE ABUSE
top
Drug Delivery Systems
- Rutgers (U.S. Patent No. 5,560,922): TRANSDERMAL ABSORPTION DOSAGE UNIT USING A POLYACRYLATE ADHESIVE POLYMER AND PROCESS
- U.S. Patent No. 4,708,834) "Preparation of Gelatin-Encapsulated Controlled Release Composition"
- U.S. Patent No. 5,368,581) "Method for Using a Packaging System with folded Applicator Pads for Drug Delivery"
top
Medical Devices
- U.S. Patent No. 4,619,657 "Flexible Intraocular Lens Holder"
- U.S. Patent No. 5,073,171 "Biocompatible Materials Comprising Albumin-Binding Dyes"
- U.S. Patent No. 5,152,784 "Prosthetic Devices Coated with a Polypeptide with Type IV Collagen Activity"
top
DNA Isolation and Synthesis
- U.S. Patent No. 5,023,171) "Method for Gene Splicing By Overlap Extension Using PCR"
- U.S. Patent No. 5,243,039) "Bacillus MGA3 Aspartokinase II Gene"
top
Vaccines
- EndoBiologics (US Pat No 7,014,857): Anti-Sepsis Conjugate Vaccine
- Mikogen (US Patent No. 6,183,755): ACTIVE PROTEINS FROM BORRELIA BURGDORFERI
- Iowa State University (U.S. Pat. No. 5,419,907): "Pathogenic Porcine Respiratory Coronavirus"
- University of Minnesota (U.S. Patent No. 4,721,617) "Vaccine against Lyme Disease"
- University of Minnesota (U.S. Patent No. 5,843,462) "Diphtheria Toxin Epitopes"
top
Analytical Techniques
- University of Virginia (US Patent No. 6,099,821): NUCLEAR SCINTIGRAPHIC ASSESSMENT OF MUCOSAL FUNCTION
- Mayo Clinic (US Patent No. 5,989,198): USE OF CAPILLARY ELECTROPHORESIS TO DETERMINE GLOMERULAR FILTRATION RATE USING IOTHALAMATE
- Iowa State University (U.S. Pat. No. 5,753,454): SEQUENCING OF OLIGOSACCHARIDES: THE REAGENT ARRAY - ELECTROCHEMICAL DETECTION METHOD
- NeoRx (U. S. Pat. No. 5,595,722): METHOD FOR IDENTIFYING AN AGENT WHICH INCREASES TGF-BETA LEVELS
- Iowa State University (U.S. Pat. No. 5,543,618): CAPILLARY ZONE ELECTRPHORESIS - MASS SPECTROMETER INTERFACE
top
|
|
 
|
